Clinical Trials
5 trialsNCT02584829 2022-03-22
Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
Fred Hutchinson Cancer Center
Phase 1/2 Terminated
NCT00031083 2020-11-17
Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas
Biogen
Phase 1 Completed
NCT02530047 2019-07-18
Mesenchymal Stem Cells (MSC) for Ovarian Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT01758458 2017-04-19
Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma
Fred Hutchinson Cancer Center
Phase 1/2 Terminated
NCT00085306 2015-10-02
Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
Case Comprehensive Cancer Center
Phase 2 Completed